11 Most Profitable NASDAQ Stocks to Buy Now
Earlier on May 30, Siebert Financial CIO Mark Malek appeared on CNBC to discuss the tariff headwinds swirling around the markets and which sectors could then rise above the noise...
Posts Tagged ‘NASDAQ:REGN’
8 Best Inexpensive Stocks to Buy Right Now
On June 7, Torsten Slok, Apollo Global Management, joined 'Closing Bell Overtime' on CNBC to discuss the US jobs report and the broader economic landscape.
JPMorgan Calls the Selloff Excessive, Trims Regeneron Pharmaceuticals, Inc. (REGN) Price Target
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the 13 Biotech Stocks with Huge Upside Potential.
13 Biotech Stocks with Huge Upside Potential
The FDA Commissioner Marty Makary stated the FDA will reach its 2025 drug approval targets despite severe workforce reductions.
Regeneron Pharmaceuticals, Inc. (REGN): A Bull Case Theory
We came across a bullish thesis on Regeneron Pharmaceuticals, Inc. (REGN) on Notes From The Beauty Contest’s Substack.
Morgan Stanley Trims Regeneron (REGN) Price Target, Maintains Overweight Rating
Morgan Stanley has lowered its price target on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) to $755 from $958, while maintaining an Overweight rating on the stock.
Regeneron Pharmaceuticals, Inc. (REGN)’s Weight-Loss Drug Aids Muscle Preservation in Wegovy Users
Regeneron Pharmaceuticals, Inc.
Regeneron (REGN) Downgraded at RBC Capital, Price Target Cut Sharply
On May 30, RBC Capital analyst Brian Abrahams downgraded Regeneron Pharmaceuticals Inc.
Why Regeneron Pharmaceuticals, Inc. (REGN) Crashed Last Week
We recently published a list of These 10 Stocks Just Rocked The Market.
Regeneron Pharmaceuticals, Inc. (REGN) Shares Plunge Despite Positive Phase 3 Itepekimab Results
Regeneron Pharmaceuticals, Inc.
Why Regeneron Pharmaceuticals, Inc. (REGN) Crashed On Friday
We recently published a list of These 10 Stocks Lost This Much Today. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc.
RBC Reaffirms Outperform on Regeneron (REGN) Ahead of Key COPD Drug Results
Analyst Brian Abrahams reiterated an Outperform rating and a price target of $943 for Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on May 29.
Regeneron Pharmaceuticals, Inc. (REGN) Licenses Gibson SOLA Platform to Boost R&D Efficiency
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has entered a key licensing agreement with Telesis Bio Inc. to integrate the innovative Gibson SOLA system into its laboratories.
Jim Cramer Reveals “Quiet” Stock That Goes Up In This List Of 12 Stocks
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer commented on the recent downgrade of US credit.
Regeneron Pharmaceuticals to Acquire 23andMe for $256M
23andMe had filed for bankruptcy protection in March this year, while REGN was the sole bidder for its assets.
10 Worst Blue Chip Stocks to Buy
As per Niamh Brodie-Machura, Co-Chief Investment Officer at Fidelity International, the effect of tariffs is expected to shift lower as and when the deals are made, supply chains...
10 Jim Cramer Stocks with Huge Upside Potential
“I want to pull back the curtain and show you how a professional looks for stocks to buy and knows what to sell. There's no magic. There's no hidden talent.
11 Cheap ESG Stocks to Buy According to Hedge Funds
These days, it seems like everyone wants to wear the “saving the world” cape.
Billionaire Mario Gabelli’s 10 Large-Cap Stock Picks with Huge Upside Potential
Mario Gabelli needs no introduction, having risen to become one of the most successful money managers on Wall Street, backed by a research-driven equity investment style.
Jim Cramer Listed 20 Best Performing Stocks of the Last 20 Years
“This week we're celebrating the show's 20th anniversary, a little over a month late, but better late than never.
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2025 Earnings Call Transcript
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2025 Earnings Call Transcript April 29, 2025Regeneron Pharmaceuticals, Inc. misses on earnings expectations.
7 Most Profitable Biotech Stocks To Buy Right Now
With improved market conditions, innovative breakthroughs, and more investor interest, the biotechnology industry is gaining new traction.
11 Blue Chip Stocks to Invest in at 52-Week Lows
For the first time since 2023, the S&P 500 was seen in the market correction territory, according to US Bank (Wealth Management).
12 Most Promising Biotech Stocks According to Wall Street Analysts
The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.
11 Best Extremely Profitable Stocks to Buy According to Analysts
We recently covered 10 Best Stocks to Buy Now For the Long Term, where we talked about the market outlook amidst the tariff situation and uncertainty.
15 Best Biotech Stocks to Buy According to Billionaires
Although biotech stocks had a "challenging" year in 2024, JPMorgan believes that some of the industry's companies could see significant growth in the months to come.
Jim Cramer’s Latest Stock Moves: Top 10 Calls
Jim Cramer in a recent program on CNBC expressed his frustration over the recent market selloff following tariff uncertainties.
What Did Jim Cramer Say About These 19 Stocks Recently?
Jim Cramer kicked off his latest episode of Mad Money by highlighting the wild swings in the market, the ongoing trade war with Canada, and the growing concerns about tariffs ...
11 Best Pharma Stocks to Buy According to Hedge Funds
The US pharmaceutical sector is experiencing a distinct trend never seen before with large American pharma companies continually looking for medicines in China.
11 Oversold Blue Chip Stocks to Buy According to Hedge Funds
The uncertainty related to the tariff announcements continues to influence Wall Street.
10 Worst Performing Large Cap Stocks to Buy According to Analysts
On January 21, Russell Investment released its Equity Factor report highlighting key trends and performances in global equity markets during the fourth quarter of 2024.
15 Stocks That Will Go to The Moon According to Analysts
While stocks initially fell based on worries regarding Trump tariffs on America’s major trading partners, major indexes recovered from their initial losses as the President ...
12 Best Growth Stocks to Invest In According to Analysts
Companies experiencing above-average earnings growth, which is often fueled by innovations and market expansions, are known as growth stocks.
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q4 2024 Earnings Call Transcript
Operator: Hello, and welcome to Regeneron Pharmaceuticals Fourth Quarter 2024 Earnings Conference Call. My name is Tawanda, and I will be your operator for today's call.
10 Best Cancer Stocks to Buy According to Hedge Funds
Cancer is the second leading cause of death across the globe, second to cardiovascular disease.
12 Best S&P 500 Stocks to Invest in According to Analysts
2024 was a memorable year for the broad market index, which posted a gain of 23.31%, building on the 24.2% return in 2023.
12 Best Depressed Stocks to Invest in Now
The US stocks ended 2024 with a healthy Q4, as the equity markets were primarily aided by solid economic growth, healthy earnings momentum, and the expectations of the rate cuts...
10 Best Stocks to Buy and Hold For 2025
Stocks have been performing well lately as they seem to have been influenced by the excitement around artificial intelligence (AI) as well as the new administration.
10 Best Falling Stocks to Invest in Right Now
The overall stock market has been in an uptrend, as depicted by major indices trading near all-time highs.
9 Stocks on Jim Cramer’s Radar
Jim Cramer, host of Mad Money, recently emphasized the importance of long-term investing, urging investors to focus on the growth prospects of certain pharmaceutical stocks while...
Jim Cramer Discusses Joe Rogan, Elon Musk, And These 13 Stocks
In one of his latest appearances on CNBC's Squawk on the Street, Jim Cramer started the morning by commenting on the latest Producer Price Index (PPI) release.
Jim Cramer’s Bold Predictions About These 10 Healthcare Stocks
Healthcare has been one of Jim Cramer's favorite topics lately.
12 Best Weight Loss Stocks to Buy According to Hedge Funds
Most people have at some point sought to include weight loss and physical exercise in their daily life.
Jim Cramer’s Lightning Rounds: 12 Stocks Under the Spotlight
Jim Cramer, host of Mad Money, recently discussed the outlook for the stock market following a year of strong gains, cautioning that investors’ overly optimistic expectations...
10 Most Promising Cancer Stocks According to Hedge Funds
According to the World Health Organization (WHO), cancer remains one of the leading causes of death globally, responsible for nearly 10 million deaths in 2020, or about one in...
10 Best Genomics Stocks To Buy Right Now
Genomics is the study of genes and how they function.
Here’s Why Regeneron Pharmaceuticals (REGN) Declined in Q3
Bronte Capital, an investment management company, released its “Amalthea Fund” third-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q3 2024 Earnings Call Transcript
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q3 2024 Earnings Call Transcript October 31, 2024Regeneron Pharmaceuticals, Inc. beats earnings expectations.
What Makes Regeneron Pharmaceuticals (REGN) an Attractive Investment Opportunity?
Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
10 High Growth NASDAQ Stocks That Are Profitable in 2024
Malcolm Ethridge, Capital Area Planning Group managing partner, joined CNBC to talk about where the market could go and his sentiment regarding the AI and overall tech sector.
